Facebook
Twitter
LinkedIn
Forward
In June of 2023 the AASLD updated the nomenclature for NAFLD to Metabolic dysfunction-Associated Steatotic Liver Disease(MASLD).
|
Obesity is one of the leading causes of preventable death. Obesity-related increases metabolic and cardiovascular risk occur at a lower body mass index in Asian adults.
|
Is the intersection of Childhood Obesity and pediatric sleep problems merely confined to a discussion of poor sleep habits leading to weight gain?
|
Fitmate Coach was founded with a mission to shake up the field of human weight loss coaching by leveraging newly emerging technology to make it more affordable, more scal
|
Obesity is one of the leading causes of the development of type 2 diabetes mellitus.
|
Insulin resistance (IR) is a common biochemical abnormality in patients with excess adiposity, obesity, and its complications.
|
Obesity is emerging as a serious and complex health condition affecting about 1 billion people in the world.
|
The number of non-nutritive sweeteners (NNS) available, both synthetic and natural, has increased rapidly in recent years.
|
Childhood obesity is a multifaceted health challenge.
|
Obesity pharmacotherapy often is solely equated as therapeutic use of anti-obesity medications (AOMs). In this session, two important factors in obesity pharmacotherapy will be discussed.
|